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β SheetThe gp41 protein of the Human Immunodeﬁciency Virus (HIV) catalyzes fusion betweenHIV and host cell mem-
branes. The ~180-residue ectodomain of gp41 is outside the virion and is the most important gp41 region for
membrane fusion. The ectodomain consists of an apolar fusion peptide (FP) region hypothesized to bind to the
host cell membrane followed by N-heptad repeat (NHR), loop, and C-heptad repeat (CHR) regions. The present
study focuses on the large gp41 ectodomain constructs “Hairpin” (HP) containing NHR + loop + CHR and
“FP–Hairpin” (FP–HP) containing FP + NHR + loop + CHR. Both proteins induce rapid and extensive fusion of
anionic vesicles at pH 4 where the protein is positively-charged but do not induce fusion at pH 7 where the pro-
tein is negatively charged. This observation, alongwith lack of fusion of neutral vesicles at either pH supports the
signiﬁcance of attractive protein/membrane electrostatics in fusion. There are two kinetically distinct fusion pro-
cesses at pH 4: (1) a faster ~100 ms−1 process with rate strongly positively correlated with vesicle charge; and
(2) a slower ~5 ms−1 process with extent strongly inversely correlated with this charge. The slower process
may bemore physiologically relevant because HIV/host cell fusion occurs at physiologic pHwith gp41 restricted
to the narrow region between the twomembranes. Previous solid-state NMR (SSNMR) of membrane-associated
FP–HPhas supported protein oligomerswith FP's in an intermolecular antiparallel sheet. Therewas an additional
population of molecules with α helical FPs and the samples likely contained a mixture of membrane-bound
and -unbound proteins. For the present study, samples were prepared with fully membrane-bound FP–HP
and subsequent SSNMR showeddominantβ FP conformation at both lowandneutral pH. SSNMRalso showed close
contact of the FPwith the lipid headgroups at both lowand neutral pHwhereas theNHR+CHR regions had contact
at low pH and were more distant at neutral pH, consistent with the protein/membrane electrostatics. This article is
part of a Special Issue entitled:NMR Spectroscopy for Atomistic Views of Biomembranes and Cell Surfaces. Guest
Editors: Lynette Cegelski and David P. Weliky.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Human immunodeﬁciency virus (HIV) is a class I enveloped virus
surrounded by a membrane obtained from an infected host cell during
viral budding [1]. Uninfectedmacrophage andThelper cells are targetedR, C-heptad repeat; FP, fusion
HIV, human immunodeﬁciency
pinning; na, natural abundance;
G, phosphatidylglycerol; PS,
nce; SSNMR, solid-state nuclear
troscopy for Atomistic Views of
egelski and David P. Weliky.
1 517 353 1793.
iky).by HIVwith subsequent joining (fusion) of the HIV and cell membranes
and deposition of the viral capsid inside the cell. Infection ismediated by
gp160 which contains non-covalently-associated gp41 and gp120 sub-
unit proteins. Virion-associated gp160 is likely trimeric [2]. The gp41
is a monotopic protein of the viral membrane with ~180-residue
extraviral and ~150-residue intraviral domains (Fig. 1). Gp120 has
~500 residues and associated with the gp41 ectodomain. The gp41
ectodomain plays a critical role in fusion and includes a ~20-residue
fusion peptide (FP), N-heptad repeat (NHR), loop, C-heptad repeat
(CHR), andmembrane-proximal external region (MPER). Fusionmodels
typically show partial insertion of the FP in the cell membrane and
partial insertion of the MPER in the viral membrane. High-resolution
structures of the gp41 ectodomain lacking the FP and MPER show a
helical hairpin with antiparallel NHR and CHR helices [3–5]. In addition,
the structures (at N2 mM protein concentration and pH 3) show a
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NHRs and three antiparallel helical CHRs closely packed in the exterior
groves of the NHR bundle. Because of its thermostability, the hairpin
structure has been considered to be the ﬁnal state of the gp41
ectodomain during fusion. At lower protein concentrations, the
ectodomain remains highly helical but is monomeric [6,7]. The
ectodomain can also be hexameric or more highly aggregated and
the oligomerization states depend on pH, protein sequence, and
solution additives [7,8]. Protein monomers are also predominant at
low pH for gp41 constructs that include the TM domain although it is
not known whether or not the TM domains of the trimer dissociate
during HIV/cell fusion [9].
Experiments and models support lipid mixing between the outer
leaﬂets of theHIV and cellmembranes as theﬁrstmembrane topological
change during fusion [1]. The resultantmembrane state is “hemifusion”,
i.e. a shared bilayer interface between HIV and the cell but no mixing of
contents between the two bodies. The shared bilayer then breaks to
form a “fusion pore” which then expands to create a single contiguous
bilayer which envelopes the HIV capsid and cell. Although the relative
timings of ectodomain and membrane topological changes are still
under investigation, some experiments have been interpreted to sup-
port formation of a ﬁnal gp41 state after lipid mixing and fusion pore
creation and before pore expansion [10]. The effects of gp41 mutations
on gp160-mediated fusion andHIV infection have also been investigated.
One signiﬁcant result was trans-dominant reduction in fusion and
infectionwith the V2Emutation in the FP region of gp41 [11]. This result
supports a requirement of multiple gp41 trimers for fusion [12].
The present paper focuses on the “hairpin” (HP) and “FP-hairpin”
(FP-HP) large ectodomain constructs that respectively include much
of the NHR + CHR and FP + NHR + CHR regions [13]. Fig. 1 displays
their sequences which are derived from the HXB2 laboratory strain of
HIV. Both proteins have a stableNHR/CHRhelical fold and induce vesicle
fusion under some conditions [14,15]. The ﬁnal state is typically amulti-
vesicle aggregate similar to the multicellular “syncytia” aggregates that
form in cell culture with HIV infection [16]. Intervesicle content mixing
has not typically been observed in protein-induced vesicle fusion
because of the rapid leakage from the vesicles.
Studies-to-date on large ectodomain constructs like HP and FP-HP
have both provided ideas and raised questions relevant to fusion.(HP)
(FP-HP)
Fig. 1. (A) Ectodomain of the HIV gp41 protein showing domains including fusion peptide (FP)
region (MPER). (B, C) Amino acid sequences of the hairpin (HP) and FP-hairpin (FP-HP) prote
laboratory strain of HIV-1. Using gp160 numbering, HP includes [535–581(M535C)]-[SGGRGG]-
for HP includes much of the NHR for HP and the ﬁrst bracket for FP-HP includes the full FP an
intervening SGGRGG is a non-native loop shorter than the ~20-residue native loop but still alloSome results support requirements of low pH (3–4) and anionic lipids
for rapid and extensive vesicle fusion [15,17,18]. To date, different
studies used vesicles with either phosphatidylserine (PS) or
phosphatiylglycerol (PG) anionic lipids but there has not been direct
comparison between the two lipid types. For vesicles with PG, there
was little fusion at pH 7. The ectodomain is positively charged at pH 4
and negatively charged at pH 7 so the combination of low pH and
anionic lipids may reﬂect an underlying requirement for fusion of
attractive protein/vesicle electrostatic energy. This energy could
increase protein binding and/or contribute to the activation energy of
fusion, and/or locally heat the membrane. At pH 4, the electrostatic
energy will be different for PG and PS lipids because they carry full
and partial negative charges, respectively. Protein binding to vesicles
at pH 7 and consequent fusionmay also be impacted by the aggregation
of ectodomain protein in the pH 7 solution [7,19]. By contrast, the pro-
tein is soluble at pH≤ 4 and is predominantly monomeric for [protein]
b100 μM. Because of gp41 ectodomain aggregation at neutral pH, many
biophysical studies including high-resolution structures have used
stock protein solutions with pH ≤ 4. Example studies and results for
HP protein include circular dichroism which showed N95% helicity at
ambient temperature and calorimetrywhich showed amelting temper-
ature of 110 °C and melting enthalpy of 65 kcal/mol [13,14]. Similar
results were obtained for FP-HP and other large ectodomain constructs
[17].
Solid-state NMR (SSNMR) spectroscopy has also been applied to
probe the structure of FP-HP in its membrane-associated form [14].
Protein stock at low pH was added dropwise to vesicle suspensions
maintained at neutral pH, followed by centrifugation and harvesting
the pellet for SSNMR. The spectra were consistent with a highly helical
hairpin domain and a ~1:1 mixture of molecules with either α helical
or β sheet FPs. The β sheet was formed by multiple proteins whose
FPs were arranged in antiparallel rather than parallel geometry [20].
There was also a distribution of antiparallel β sheet registries. If the
highly helical hairpin region is a molecular trimer, the antiparallel FP
β sheet could reﬂect interleaved FPs from two different trimers. This re-
sult correlates with predominant hexamers for gp41 ectodomain con-
structs under some conditions [7,8]. Because of protein aggregation in
neutral pH aqueous solution, the SSNMR samples could also have
contained a fraction of aggregated protein that was not membrane-, N-heptad repeat (NHR), loop, C-heptad repeat (CHR), and membrane-proximal external
ins with color-matching with panel A. The sequences of HP and FP-HP are from the HXB2
[628–666] and FP-HP includes [512–581(M535C)]-[SGGRGG]-[628–666]. The ﬁrst bracket
d much of the NHR. For both constructs, the third bracket includes much of the CHR. The
ws formation of a stable hairpin with antiparallel NHR and CHR helices.
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associated FP-HP with β or α FPs were not known.
The present work addresses some questions raised by these earlier
studies. Signiﬁcant results include negligible protein-induced fusion of
neutral vesicles at either low or neutral pH and negligible fusion of
anionic vesicles at neutral pH. Rapid and extensive fusion was observed
for anionic vesicles at low pH. Fusion rates and extents were analyzed
for vesicles with different fractions of PG and PS lipids and two kinetic
processes were detected. The rate of the faster process was strongly
positively correlated with vesicle anionic charge while the extent of
the slow process was inversely correlated with this charge. The slow
process may be more relevant for HIV/cell fusion at neutral pH.
Fully-membrane-associated FP-HP samples were prepared with
anionic vesicles and low pH where the protein did not aggregate.
The SSNMR spectra of these samples showed that the β FP structure
was predominant. The β structure was also predominant when the
sample pH was increased to 7. Protein-to-lipid headgroup contact
in both low and neutral pH samples was probed by protein 13CO to
lipid 31P SSNMR. There was greater contact for the NHR + CHR re-
gion at low pH relative to neutral pH which is consistent with
protein/membrane electrostatics. There was close membrane con-
tact of the FP at both pH's which is consistent with FP insertion via
the hydrophobic effect.
2. Materials and methods
2.1. Materials
Lipidswere purchased from Avanti Polar Lipids. Most other reagents
were purchased from Sigma-Aldrich. HP contains N-heptad repeat
(NHR) + short non-native loop + C-heptad repeat (CHR) and FP-HP
contains FP+HP(Fig. 1). Proteinwith non-native loop has similar phys-
ical properties to protein with the ~20-residue native loop including
very high fractional helicity and Tm ≈ 110 °C [13,14,17]. The gp160-
numbered amino-acid sequences from the HXB2 laboratory strain of
HIV-1 are: FP (512–534); NHR (535(M535C)-581); and CHR (628–
666). FP-HP typically had a single backbone 13CO label and a single
backbone 15N label in the FP region that were directly-bonded.
FP-HP_A1CV2N had A1 13CO and V2 15N labels, FP-HP_L7CF8N had
L7 13CO and F8 15N labels, and FP-HP_G10CF11N had G10 13CO and
F11 15N labels.
HP and FP-HP proteins were produced and puriﬁed as previously
described [13,15,20]. Brieﬂy, FP was synthesized by t-boc chemical
synthesis and the subsequent cleavage with hydrogen ﬂuoride was
done by Midwest Biotech. HP was synthesized by bacterial expression
and FP-HP was produced using native chemical ligation of puriﬁed FP
and HP. Puriﬁcations were done by reversed-phase HPLC and ﬁnal
purities were typically N95% as assessed by mass spectrometry. Typical
puriﬁed yields were N100 mg FP per t-boc synthesis, ~50 mg HP per L
bacterial culture, and ~5 mg FP-HP from a ligation reaction with
~10 mg FP and ~50 mg HP.
2.2. Protein-induced vesicle fusion
Vesicles were prepared with lipid and cholesterol (Chol) in 2:1 mol
ratio which was intermediate between the ratios for the membrane of
host cells and the membrane of HIV [21]. The membranes always
contained electrically neutral phosphatidylcholine (PC) lipids because
this is the most common headgroup of membranes of cells infected by
HIV. The membranes typically contained an anionic lipid (AL) with
either phosphatidylglycerol (PG) or phosphatidylserine (PS) headgroup
and the AL:PC mole ratio varied between 0 and 1. Lipids typically
contained 1-palmitoyl-2-oleoyl acyl chains.
A corollary “labeled” vesicle sample was prepared for each
“unlabeled sample” described above and contained additional
0.02 mol fractions of ﬂuorescent lipid {N-(7-nitro-2,1,3-benzoxadiazol-4-yl)(ammonium salt) dipalmitoylphosphatidylethanolamine} and
quenching lipid {N-(lissamine rhodamine B sulfonyl)(ammonium salt)
dipalmitoylphosphatidylethanolamine}. For each sample, lipid and
Chol were dissolved in chloroform:methanol (9:1 v/v) and excess
solvent was removed by rotary evaporation. The ﬁlm was suspended
in 25 mM citrate buffer, homogenized by freeze-thaw cycles, and
extruded through a ﬁlter with 100 nm diameter pores. Unlabeled and
labeled vesicle solutions were mixed in a 9:1 ratio and the pH was
adjusted using 1 M HCl or 1 M NaOH. Protein-induced vesicle fusion
was detected via lipid mixing between labeled and unlabeled vesicles
with consequent higher ﬂuorescence because of longer average
ﬂuorophore-quencher distance. Fluorescence was detected: (1) for
the initial labeled + unlabeled vesicle solution; (2) with time-
resolution after addition of an aliquot of protein solution; and
(3) after addition of an aliquot of Triton X-100 detergent that
solubilized the vesicles and maximized ﬂuorescence. The respective
ﬂuorescence valueswere F0, F(t), and Fmax and the percent vesicle fusion
was calculated:
M tð Þ ¼ F tð Þ–F0ð Þ= Fmax–F0ð Þ½   100: ð1Þ
Typical experimental conditions included: (1) PTI QW4 ﬂuorimeter
with 467 nmexcitation and 530 nmdetectionwavelengths; (2) vesicles
in 1400 μL volume and [total lipid] = 150 μM and [Chol] = 75 μM;
(3) constant stirring; (4) protein:lipid (PC + AL) = 1:700 achieved
with a 7.5 μL aliquot of 40 μM protein in 10 mM formate buffer at
pH 3.2with 0.2 μMTCEP reducing agent; (5) syringe injection of protein
solution to reduce assay dead time to ~1 s; (6) 1 s time increments for
F(t); and (7) 0.08% w/v Triton X-100 achieved with a 12 μL aliquot of
10% Triton X-100. The protein:lipid = 1:700 ratio was chosen in part
because there was light scattering from the fused vesicles for higher
ratios.2.3. SSNMR sample preparation
Vesicles were prepared as described abovewith composition PC:PG:
Chol (8:2:5) mole ratio. Ether-linked lipids were used because they
lacked carbonyl (CO) carbons and therewas consequently lower natural
abundance 13CO SSNMR signal. Protein solution was added dropwise to
the vesicle solution with constant stirring, themixture was centrifuged,
and the proteoliposome pellet was packed into a magic angle spinning
(MAS) SSNMR rotor. Typical experimental conditions included:
(1) 50 μmol lipid, 25 μmol Chol, and 1 μmol protein; 2mL initial volume
of vesicle solution; and 10 mL volume of protein solution in 10 mM
formate buffer at pH 3.2; (3) centrifugation at 30,000 g; and (4) MAS
rotor with 4 mm diameter and ~50 μL sample volume. For “method
1”, the vesicle solution was buffered with 5 mM HEPES at pH 7.2 and
this pH was maintained during protein addition. For “method 2”, the
vesicle solution was buffered with 10 mM formate at pH 3.2 and there
appeared to be extensive protein-induced vesicle fusion as evidenced
by opacity and precipitation of proteoliposomes. After SSNMR spectra
were obtained for the sample at pH 3.2, the sample pH was sometimes
increased by: (1) removal of the pH 3.2 pellet from the SSNMR rotor;
and (2) suspension in 250 μL of 25 mM HEPES buffer at pH 7.2;
(3) centrifugation; and (4) repacking of the pH 7.2 pellet in the rotor.
After SSNMR were obtained for the pH 7.2 “pH-swapped” sample, the
sample pH was sometimes taken back to pH 3.2 by: (1) removal of the
pH 7.0 pellet from the rotor; and (2) suspension in 500 μL of 50 mM
formate buffer at pH 3.2; (3) centrifugation; and (4) repacking of the
pH 3.2 pellet in the rotor. SSNMR spectra were then obtained for this
“reverse-swapped” sample.
Fig. 2. Representative time-courses of protein-induced vesicle fusion for protein:total
lipid mole ratio = 1:700 at pH (A) 3.5 and (B) 4.0. Chol is not considered in the total
lipid quantity. Best-ﬁts are displayed in black.
292 P.U. Ratnayake et al. / Biochimica et Biophysica Acta 1848 (2015) 289–2982.4. SSNMR spectroscopy
Spectra were collected on a 9.4T instrument (Agilent Inﬁnity Plus)
with triple-resonance MAS probe tuned to either 1H, 13C, and 15N
frequencies or 1H, 13C, and 31P frequencies. 13C S0 and S1 rotational-
echo double-resonance (REDOR) spectra were acquired [22,23]. The
reduction in 13CO intensity in the S1 spectrum relative to S0 was used
to probe proximity of labeled (lab) and natural abundance (na) 13CO
nuclei to either lab FP-HP 15N or membrane headgroup 31P nuclei. In
particular, the 13CO–15N ΔS (=S0 − S1) REDOR difference spectrum
was dominated by the signal of the lab 13CO site in the FP region with
attenuation of signals from the other ~130 na 13CO sites in the protein
[24]. Spectral contributions with either lower or higher 13CO shift
could then be respectively assigned to molecules with either β or α
conformation at the lab site and the relative β andα populations deter-
mined from the signal intensities [25,26]. 13CO–31P REDOR spectrawere
acquired for different dephasing times (τ's) and the rate and extent of
buildup of the 13CO ΔS/S0 intensity ratio with τ was used to assess the
proximity of lab and na 13CO sites to the membrane lipid headgroups
[27].
Calibration of the rf ﬁelds and validation of the experimental setups
were done as described previously [28,29]. Typical experimental condi-
tions included: (1) 8.0 or 10.0 kHz MAS frequency and sample cooling
with nitrogen gas at−50 °C to reduce molecular motion that reduces
signal intensity; (2) 2.0 ms dephasing time for 13CO–15N REDOR and
an array of dephasing times between 2.0 and 48.0 ms for 13CO–31P
REDOR; (3) 13C π pulse at the end of each rotor cycle during the
dephasing period (except the last cycle) and 15N or 31P π pulse at the
midpoint of each rotor cycle during the dephasing period of the S1
acquisition; (4) 1H π/2 and cross-polarization ﬁelds of ~50 kHz and
decoupling ﬁeld of ~90 kHz; (5) 13C ramped cross-polarization ﬁeld
from 40 to 45 kHz and π pulse ﬁeld of ~45 kHz; (6) 15N and 31P π
pulse ﬁelds of ~25 and ~50 kHz, respectively; (7) pulse delay of 1 s;
(8) alternate acquisition of S0 and S1 scans with summing of 5000–
50,000 scans; (9) spectral processing with 100 Hz Gaussian line broad-
ening and baseline correction; (10) external 13C shift referencing using
the methylene peak of adamantane at 40.5 ppm which allows direct
comparison of the SSNMR 13CO shifts to database distributions of
liquid-stateNMR 13COα and 13COβ shifts [30]; and (11) 13COα intensities
determined from the integration of the 180→ 176 ppm shift interval of
13C-31P REDOR spectra of the FP-HP_G10CF11N sample, G10β intensities
from integration of the 172→ 169 ppm shift interval of this sample, and
A1β intensities from the integration of the 174.5→ 171.5 ppm shift
interval of the FP-HP_A1CV2N sample.
3. Results
3.1. Vesicle fusion requires attractive electrostatic energy
For either HP or FP-HP, the protein charge is ~+9 at pH 3.5, ~+7 at
pH 4.0 and ~−2 at pH 7.0. For protein:lipid mole ratio = 1:700, fusion
was only observed at low pH with anionic vesicles (Fig. 2). There was
negligible fusion of anionic vesicles at neutral pH and also little fusion
with neutral vesicles at either low or neutral pH. These data support a
fusion requirement of attractive protein/vesicle electrostatic energy
which is likely needed for signiﬁcant binding. For a given protein and
vesicle composition, therewas typically greater fusion at pH 3.5 relative
to pH 4.0.
3.2. Fast and slow fusion
The time courses of fusion of anionic vesicles at low pH,M(t), were
well-ﬁtted with either the sum of a fast and slow exponential buildup:
M tð Þ ¼ Mf 1–e–k f
t þMs 1–e–ks
t  ð2aÞor a single slow exponential buildup:
M tð Þ ¼ Ms 1–e–ks
t 
: ð2bÞ
The dark lines in Fig. 2 are the best-ﬁts of the experimental data. Use
of one vs two buildups for ﬁtting was determined by visual comparison
of the best-ﬁt and the experimental data. In practice, the fast buildup
was used for |charge/lipid| ≥ 0.12. The kf and ks are the fusion rate
constants with kf in the 30–200 ms−1 range and ks in the 1–9 ms−1
range. The Mf and Ms are the long-time fusion extents of the fast and
slow processes, respectively. Table 1 lists the ﬁtted rates and extents
and Fig. 3 displays bar plots of the pH 3.5 values. For each set of assay
conditions, data were acquired in triplicate and each data set was ﬁtted
independently. Each reported parameter uncertainty is the standard
deviation among these replicate values. The uncertainty from a single
replicate ﬁtting is much smaller, typically b1% of the best-ﬁt parameter
value.
3.3. Fast rate is strongly positively correlated with lipid charge
The rate of fast fusion (kf) is highly positively correlated with
the average anionic lipid charge, e.g. kf≈ 200 ms−1 for charge/lipid ≈
Table 1
Best-ﬁt parameters of vesicle fusion.a,b
Vesicle composition Charge/lipidc kf (ms)−1 Mf (%) ks (ms)−1 Ms (%)
Hairpin pH 3.5
PC:PG:Chol (5:5:5) −0.485 178(26) 7.1(9) 8(1) 3.4(4)
PC:PG:Chol (8:2:5) −0.194 42(5) 6.8(5) 4.2(5) 7.8(1)
PC:PG:Chol (9:1:5) −0.097 – – 2.4(2) 29.1(9)
PC:PS:Chol (5:5:5) −0.120 34(4) 3.6(7) 4.5(4) 12(4)
PC:PS:Chol (8:2:5) −0.048 – – 1.4(1) 37(3)
PC:PS:Chol (9:1:5) −0.024 – – 1.4(2) 35(4)
FP-hairpin pH 3.5
PC:PG:Chol (5:5:5) −0.485 216(61) 9.6(5) 9(3) 4.2(8)
PC:PG:Chol (8:2:5) −0.194 51(12) 10(2) 5.2(7) 10(1)
PC:PG:Chol (9:1:5) −0.097 – – 8(1) 46(5)
PC:PS:Chol (5:5:5) −0.120 58(11) 15(3) 9(2) 14(3)
PC:PS:Chol (8:2:5) −0.048 – – 3.7(1) 50(1)
PC:PS:Chol (9:1:5) −0.024 – – 1.9(1) 50(2)
Hairpin pH 4.0
PC:PG:Chol (5:5:5) −0.495 135(17) 5.3(2) 4(2) 1.3(4)
PC:PG:Chol (8:2:5) −0.198 27(1) 5(1) 2.7(1) 9(2)
PC:PG:Chol (9:1:5) −0.099 – – 1.3(3) 20(2)
PC:PS:Chol (5:5:5) −0.250 32(3) 3.6(9) 4.0(5) 7.7(7)
PC:PS:Chol (8:2:5) −0.100 – – 1.4(1) 23(6)
PC:PS:Chol (9:1:5) −0.050 – – 1.0(3) 11(2)
FP-hairpin pH 4.0
PC:PG:Chol (5:5:5) −0.495 201(60) 6.0(5) 15(2) 2.4(6)
PC:PG:Chol (8:2:5) −0.198 27(3) 12(1) 4.3(8) 10.8(5)
PC:PG:Chol (9:1:5) −0.099 – – 3.0(1) 43(3)
PC:PS:Chol (5:5:5) −0.250 25(4) 6(1) 3(1) 3(1)
PC:PS:Chol (8:2:5) −0.100 – – 3.7(2) 32(3)
PC:PS:Chol (9:1:5) −0.050 – – 1.4(3) 29(3)
a The assay for each set of conditions was repeated in triplicate with separate ﬁtting of
each trial. Each reported parameter value and uncertainty is respectively the average and
standarddeviation of the three replicateﬁttings. For a single data set, theﬁttinguncertainty
was typically b1% of the ﬁtted parameter value.
b Protein:total lipid mole ratio = 1:700. Chol is not included in the total lipid quantity.
c Charge/lipidwas calculated using amodel forwhich: (1) PC is uncharged; and (2) and
PG and PS are each characterized by an equilibriumHA↔ H+ + A−with pKa = 2 for PG
and 4 for PS [49].
Fig. 3. (A) Buildup rate and (B)ﬁnal extent best-ﬁt parameters at pH3.5. Each displayed pa-
rameter value and uncertainty is respectively the average and standard deviation among
three replicates with separate ﬁtting of each trial. The ﬁtting uncertainty of a parameter
for an individual trial is typically b1% of the best-ﬁt value. For PC:PG:Chol = 5:5:5
and 8:2:5 and PC:PS:Chol = 5:5:5, the ﬁtting model is a sum of a fast and a slow
exponential-buildup while for other compositions, the model is a single slow buildup.
Choice of ﬁtting model was based on visual inspection of goodness-of-ﬁt.
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observed for |charge/lipid| ≤ 0.1 which suggests that the slow process
becomes dominant under this condition. The correlation of kf with
lipid charge is further supported by similar values of kf with vesicles
with different fractions of PG or PS but similar charge/lipid, e.g. similar
kf for PC:PG:Chol = 8:2:5 and PC:PS:Chol = 5:5:5. The kf value may
be more speciﬁcally correlated to the magnitude of the attractive
protein/vesicle electrostatic energy because for the same protein and
vesicle composition, the kf at pH 3.5 (protein charge≈+9) is typically
~30% higher than the kf at pH 4.0 (protein charge≈+7). The Fig. 4A
plot of kf vs |charge/protein × charge/lipid| for HP at pH 3.5 and 4.0
illustrates the positive correlation between kf and electrostatic energy.
The typical long-time extent of fast buildup,Mf, is ~5%with little depen-
dence on charge/lipid or pH, i.e. variation in protein/vesicle electrostatic
energy.
3.4. Slow extent is inversely dependent on lipid charge
The slow process rate constant ks is typically in the 1–9 ms−1 range.
As with kf, for a given protein and pH, there is typically a positive corre-
lation between ks and |charge/lipid| and an inverse correlation with pH.
The dependences likely reﬂect a contribution from attractive protein/
vesicle electrostatic energy although the ks dependence has much
smaller magnitude than the corresponding kf dependence. There is
also strong inverse correlation of the extent Ms with |charge/lipid|,
e.g. for FP-HP induced fusion of PC:PG:Chol vesicles at pH 3.5, the
decrease of charge/lipid from−0.5 to−0.1 correlates with an increase
inMs from ~5% to ~50%. The inverse dependence ofMs on |charge/lipid|
is likely a consequence of the decrease in repulsive inter-vesicleelectrostatic energy with decreasing charge. For example, Fig. 4B plot
of Ms vs (charge/lipid)−2 has positive slope for |charge/lipid| N 0.1.
TheMs is approximately constant for |charge/lipid| b 0.1.
3.5. Higher fusion for FP-HP
For the same vesicle composition and pH, the kf or ks for FP-HP is
typically 1.5–2 times larger than the corresponding kf or ks for HP. The
Mf orMs is similarly larger too.
3.6. β Sheet FP of membrane-associated FP-hairpin
Fig. 5A displays the 13CO region of the REDOR SSNMR spectra of a
sample containing PC:PG:Chol (8:2:5) and FP-HP_L7CF8N which was
13CO-labeled at L7 and 15N-labeled at F8 in the FP region. The sample
was prepared by “method 1” with the addition of a stock protein solu-
tion to a vesicle suspension maintained at pH 7.2. The stock protein
solution was at pH 3.2 with predominant protein monomers. In the
absence of vesicles, theprotein aggregated at pH7.2. The SSNMR sample
was the pellet obtained after centrifugation of the protein/vesicle sus-
pension and this pellet contained a fraction of membrane-associated
protein and a fraction of non-membrane-associated protein that was
aggregated.
The S0 spectrum includes both the labeled (lab) L7 13CO signal as
well as natural abundance (na) 13CO signal primarily from the helical
NHR + CHR regions. Spin-counting supports a ~2:3 ratio of the lab:na
Fig. 4. Plots of (A) kf vs |(charge/protein) × (charge/lipid)| and (B)Ms vs (charge/lipid)−2.
The positive correlation of plot A supports the fast process resulting from release of
electrostatic energy from protein/vesicle binding. Plot B supports an inverse correlation
between the extent of slow fusion and inter-vesicle repulsion. Plot A displays data for
HP at pH 3.5 and 4.0 and plot B displays data for HP at pH 3.5.
Fig. 5. 13C-detect/15N-dephase REDOR SSNMR spectra of (A–C) FP-HP_L7CF8N and (D) FP-HP_G
S0 (blue) spectrum, the signals of lab nuclei are strongly attenuated in the S1 (green) spectrum
assignments are based on comparison with database distributions of 13CO shifts and with th
CHR regions. The samples contained PC:PG:Chol in 8:2:5 mol ratio and protein:lipid mole ratio
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higher shift peak at ~178 ppm that is assigned to 13COnuclei inα helical
structure and a lower shift shoulder at ~174 ppm assigned to nuclei in
antiparallel β sheet structure. Because the lab L7 13CO nucleus is
directly-bonded to the lab F8 15N nucleus, the L7 13CO signal is highly
attenuated in the S1 spectrum. The ΔS = S0− S1 difference spectrum
is consequently dominated by the lab L7 signal. The ΔS spectrum of
the method 1 sample shows β and α peaks of approximately equal
intensity with similar spectra obtained for replicate sample prepara-
tions. One of our goals was the qualitative assessment of the relative
contributions of membrane-associated and non-membrane-associated
protein to each of these peaks.
Fig. 5B displays the REDOR spectra of a FP-HP_L7CF8N sample pre-
pared by method 2 in which protein initially solubilized at pH 3.2 was
added to a vesicle suspension also at pH 3.2. Relative to theΔS spectrum
of themethod 1 sample, the ΔS spectrum of themethod 2 sample has a
more dominant β peak. The centrifugation pellet was fully membrane-
associated protein with minimal aggregated protein as evidenced by:
(1) no pellet from the method 2 protocol in the absence of vesicles;
and (2) immediate turbidity with the addition of protein consistent
with rapid protein binding and induction of vesicle fusion at pH 3.2
(Fig. 2A). The A280 of the centrifugation supernatant was used to
calculate the quantities of soluble and membrane-bound protein. The
maximum protein:lipid mole ratio of the pellet was ~0.02 and consis-
tent among replicate samples. The lab β signal is dominant after the
sample pH was swapped to 7.2 (Fig. 5C) and after reverse-swapping
to pH 3.2 (not shown). These similar β spectra obtained for the same
sample initially at pH 3.2, then at pH 7.2, and again at pH 3.2 are consis-
tent with the retention of membrane-binding for the protein at pH 7.2
even though there is electrostatic repulsion between the protein and
membrane at this higher pH. Membrane binding could be retained
through the attractive and pH-independent hydrophobic interaction
between the FP region and the membrane. The major lab β signal is
observed in replicate samples and for other lab sites of method 2
samples, e.g. G10 of a sample with FP-HP_G10CF11N (Fig. 5D). The ΔS
spectrum of FP-HP_L7CF8N precipitated at pH 7.2 in the absence of10CF11N sampleswith 2ms dephasing time. Both lab and na 13CO nuclei contribute to each
, and the ΔS= S0− S1 (red) spectrum is dominated by the lab 13CO signal. The α and β
e corresponding lab 13CO shifts of membrane-associated FP without the NHR, loop, and
≈ 0.02.
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result and the major lab β peak of method 2 samples support a domi-
nant contribution to the lab α peak of the method 1 samples from
non-membrane-associated protein aggregates.
3.7. Membrane proximities of the FP and hairpin regions
Fig. 6A–C displays 13CO REDOR spectra for 40 ms dephasing time
of fully-membrane-associated FP-HP with dephasing by the 31P
nuclei of the lipid headgroups. The samples include FP-HP_G10CF11N
at (A) pH 3.2 and (B) pH 7.2 and (C) FP-HP_A1CV2N at pH 3.2. Plots
of (ΔS/S0) vs τ are displayed for the (D) na α 13CO signal of the
G10CF11N samples at pH 3.2 and 7.2 and (E) lab G10 β signals at
pH 3.2 and pH 7.2 as well as the lab β A1 signal at pH 3.2. Some of the
(ΔS/S0) buildups are semi-quantitatively analyzed using a model of
isolated 13CO-31P spin pairs which all have the same internuclear dis-
tance r. For this model, there is a general expression for (ΔS/S0) as a
function of function r and τ which is the basis of the speciﬁc equation
to calculate the 13CO–31P distance [31]:
r A°
 
¼ 27:33 τ0:3 sð Þ1=3: ð3Þ
The τ0.3 corresponds to (ΔS/S0)= 0.3 which is typically a high-slope
region of the (ΔS/S0) vs τ buildup.
The na α signal is dominated by 13CO nuclei of the hairpin (NHR +
CHR) region (Fig. 1) because this region is highly helical whereas forFig. 6. 13C-detect/31P-dephaseREDOR SSNMR spectra of (A, B) FP-HP_G10CF11N and (C) FP-HP_A
signals and (E) labβ signals. Each (ΔS/S0) valuewas calculated from S0 and S1 13CO intensities int
calculated from the standard deviation of spectral noise values integrated over comparable intmembrane-bound protein, the FP region has predominant β structure.
This na α assignment is also evidenced by similar (ΔS/S0)α for FP-HP
samples labeled at different FP residues, e.g. A1 or G10. At pH 3.2,
there is clear buildup of (ΔS/S0)α with τ, with τ0.3≈ 0.03 s and corre-
sponding r≈ 8–9 Å. At pH 7.2, in some contrast, the (ΔS/S0)α b 0.1 for
all τ which evidences r N 12 Å for most hairpin 13CO nuclei. The nearer
(pH 3.2) and farther (pH 7.2) proximities of hairpin to the negatively-
charged membrane respectively correlate with the positive and
negative charges of hairpin region and the consequent attractive and
repulsive electrostatic energies between this region and the anionic
membrane. “Reverse-swap” samples whose pH had been cycled from
3.2 to 7.2 and back to 3.2 had (ΔS/S0)α comparable to the large values
of the original pH 3.2 samples and different than the smaller values of
the swapped pH 7.2 samples. The reversibility of the pH-dependent
variation in hairpin/membrane proximity supports fully membrane-
boundprotein inmethod 2 samples at both pH3.2 and 7.2 and contrasts
with the mixture of membrane-bound protein and non-membrane-
bound protein aggregates detected in the method 1 samples at pH 7.2.
The β signal is dominated by lab 13CO nuclei in the oligomeric anti-
parallel β sheet structure of the FP. There is rapid A1 (ΔS/S0)β buildup
at pH 3.2 with τ0.3 ≈ 0.01 s and corresponding r≈ 5–6 Å. This value
of r is consistent with van der Waals contact between the A1 residue
and the membrane for many of the FP-HP molecules. This contact is
likely due to electrostatic attraction between the A1 \NH3+ and the
negatively chargedmembrane aswell as overall FP binding to themem-
brane through hydrophobic interaction. Relative to A1 at pH 3.2, there is
smaller G10 (ΔS/S0)β buildup at both pH 3.2 and 7.2. These smaller1CV2N sampleswith 40ms dephasing time. Plots of (ΔS/S0) vs dephasing time for (D)naα
egrated over a 3–4 ppmshift interval. The typical uncertainty in a (ΔS/S0) valuewas 0.01 as
erval width.
Fig. 7. Qualitative model of FP-HP-induced fusion of anionic vesicles with FP-HP color
coding matched to Fig. 1. Monomers from solution bind to the vesicles with release of
electrostatic energy that results in fast fusion. The bound monomers also diffuse on the
vesicle surface and self-associate as small oligomers with formation of an intermolecular
antiparallel FP β sheet which is associated with slow fusion [50].
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drophobic 7LFLGFL segment of the FP region into themembrane hydro-
carbon core.
4. Discussion
4.1. Fast and slow fusion processes
One important result of the present study was detection of fast
~100 ms−1 and slow ~5 ms−1 components of vesicle fusion. The rate
constant of the fast component kf is strongly positive correlated with
|charge/lipid| and therefore the magnitude of attractive protein/vesicle
electrostatic energy (Fig. 4A). The fusion extent Mf is approximately
independent of this energy. The magnitude of this energy is 60 kJ/(mole
protein) as calculated for: (1) vesicles with 20% negatively charged
lipid; (2)monomerproteinwith+7charge; (3) boundprotein separated
by 20 Å from 50 lipid phosphate groups; and (4) aqueous media with
dielectric constant of 80. Fast fusion is attributed to the deposition of
this energy in the membrane and the consequent local membrane per-
turbation. After dissipation of this energy, fusion may arrested by
intervesicle repulsion whose magnitude also increases with |charge/
lipid|.
The kf's are ~1% of the rates of protein/vesicle (kpv) and vesicle/
vesicle (kvv) collisions [32]. Protein/vesicle electrostatics are attractive
and orientation-independent, so a protein likely binds to the vesicle
after a single collision. For protein:lipid= 1:700, each 100 nmdiameter
vesicle has ~80 bound proteins that cover ~10% of the vesicle surface.
The ratio for kf/kvv of ~0.01 may reﬂect the (0.1)2 fraction of inter-
vesicle collisionswith contact between protein regions on both vesicles.
Other collision geometries may not lead to fusion because of repulsion
between the negatively-charged vesicle surfaces.
Relative to the kf's, the ks's showweaker dependence on protein and
vesicle charges. The positive ks dependence likely reﬂects a contribution
from attractive protein/vesicle electrostatic energy. The Ms's have
strong inverse correlation on |charge/lipid| in the 0.1 to 0.5 range,
with no further increases for |charge/lipid| lower than 0.1. We assign
the slow process to fusion after dissipation of the attractive protein/
vesicle electrostatic energy with higher extents at smaller |charge/
lipid| attributed to reduced intervesicle repulsion (Fig. 4B). The slow
process occurs on the ~200 s timescale and reﬂects rare fusion events
that occur after hundreds of vesicle/vesicle collisions. The probability
of a fusogenic collision likely increases with decreased inter-vesicle
repulsive energy. The approximately constant Ms for |charge/lipid| ≤
0.1 may reﬂect competing effects of smaller intervesicle repulsion and
smaller protein/vesicle attraction that results in fewer bound proteins.
This latter effect is consistent with negligible fusion of electrically
neutral PC:Chol vesicles at either low or neutral pH.
Fig. 7 presents a qualitative model of gp41 ectodomain-induced
vesicle fusion at low pH. The fast process is attributed to bound protein
monomers that reﬂect the predominant protein state in aqueous
solution. The slow process is attributed to membrane-bound protein
oligomers which are the likely equilibrium structural state and which
may form through protein diffusion on the membrane surface on the
~200 s time scale of the slow process. For some conditions, the
displayed hexamer ≡ two trimer state is the predominant oligomeriza-
tion state for large ectodomain constructs such as HP [7,8].
4.2. Membrane-associated β FP
Fully-membrane-associated FP-HP was prepared at low pH because
the protein was predominantly monomeric in the solution and also
bound tightly to anionic membranes. Membrane-binding was retained
during a swap to neutral pH and a reverse-swap back to low pH. Protein
13CO-to-lipid 31P REDOR SSNMR spectra showed that the helical NHR
and CHR regions of FP-HP are closer to the membrane surface at low
pH than at neutral pH which correlates with the respective attractiveand repulsive protein/membrane electrostatic energy. Retention of
membrane binding at neutral pH is likely through the hydrophobic FP
region. Inclusion of this region in FP-HP also contributes to more rapid
and extensive fusion relative to HP. At either low or neutral pH, the
major population of membrane-associated FP-HP molecules have β FP
structure. Previous SSNMR showed this was an intermolecular antipar-
allel β sheet, likely an equilibrium structure as the SSNMR is done after
~1 day of sample preparation [20,33]. The oligomer with β FP's is
proposed as the catalytic structure of the slow fusion process. The FP
may locally perturb the surrounding bilayer structure of the lipids (at
equilibrium) so that there is smaller activation energy to the fusion
transition state in which lipid structures are also disordered relative to
an unperturbed bilayer [34–37].
The β FP structure of FP-HP in membranes correlates with the
previous observations of β structure of FP in membranes (without the
C-terminal hairpin) [16,26,33,38]. The β FP may therefore be an auton-
omous structure in membranes so that FP alone and the FP region of
large segments of gp41 like FP-HP may have similar structures and
locations in the membrane [39,40]. For membranes lacking Chol, there
is also a population of FP molecules with predominant α helical struc-
ture and a positive correlation between membrane Chol content and β
FP population [41,42]. We do not yet know whether this correlation
also holds for FP-HP as FP-HP samples have only been prepared with
lipid:Chol mole ratio = 2:1. We don't yet have structural data for the
FP in the membrane-associated monomer which is probably a non-
equilibrium state (Fig. 7).
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commonly observed in detergent [43,44]. The αmonomer in detergent
is probably due to: (1) entropically-driven partitioning of single
proteins into separated micelles with ~100 detergent molecules; and
(2) formation of α structure in the micelle interior because this struc-
ture maximizes intra-protein backbone hydrogen bonding in this low
dielectric environment with low water content. The β oligomer in
membranes is probably due to: (1) ~100,000 lipidmolecules per vesicle
with even larger numbers after fusion; (2) tens to thousands of protein
molecules per vesicle; and (3) formation of intermolecular β structure
that maximizes inter-protein hydrogen bonding and increases entropy
because of the distribution of intermolecular antiparallel registries and
the distribution of FP locationswithin themembrane hydrocarbon core.
4.3. α FP of aggregated FP-HP
Non-membrane-associated FP-HP aggregates at neutral pH have
~50% population of FP-HP molecules with α FP structure. Having α
rather than β FP structure suggests intermolecular contacts via protein
regions other than the hydrophobic FP. These types of contacts are
also consistent with the observed aggregation at neutral pH of HP
which lacks the FP.
4.4. Slow vesicle fusion as a model for HIV hemifusion
The lipid mixing assay of ectodomain-induced vesicle fusion corre-
lates with the initial hemifusion (joining) of viral and cell membranes.
At low pH, the protein is monomeric in solution and binding to anionic
membranes is favored by attractive electrostatics. At neutral pH, the
protein aggregates in solution and binding is inhibited by repulsive
electrostatics. HIV/cell fusion probably occurs at neutral pHwith anionic
membranes but is different from vesicle fusion at neutral pH because
viral protein aggregation is disfavored and viral protein binding to the
cell membrane is favored. These properties are the result of: (1) viral
gp41 being an integral membrane protein; and (2) spatial conﬁnement
of the viral gp41 ectodomain to the region between viral and host cell
membranes because of initial binding between the extraviral gp120
protein and cell membrane proteins. Viral fusion is therefore better
modeled by ectodomain-induced vesicle fusion at low pH because
there is minimal protein aggregation in solution and high membrane-
binding.
In addition, virus/cell hemifusion is probably better modeled by the
slow than the fast component of vesicle fusion. The fast process is highly
positively correlatedwith the attractive protein/membrane electrostatic
energy and this energy is likely small or even repulsive for viral fusion at
neutral pH. In addition, the |charge/lipid| is ~0.15 for HIV and ~0.07 for
the host cell membrane [21]. For this regime, there is maximal slow and
minimal fast vesicle fusion. To our knowledge, the viral hemifusion rate
has not been measured but the typical overall timescale for viral fusion
is ~30min [45]. Relative to the fast timescale of ~0.1min, the slow time-
scale of ~3 min also seems more reasonable for viral fusion. Correlation
of slow vesicle fusion with viral fusion suggests that the active state of
the viral gp41 ectodomain may be oligomeric with membrane-
inserted FP's in an intermolecular antiparallel β sheet (Fig. 7). This is
consistent with earlier data supporting the signiﬁcance of FP oligomers
in viral fusion and infection [11,12,32].
Although the fusion of anionic vesicles requires low pH for attractive
protein/vesicle electrostatic energy and quantitative binding, viral
fusion likely occurs near neutral pH. This holds for either direct fusion
between the viral and plasma membranes or for endocytosis with sub-
sequent fusion between the viral and endosomal membranes [46,47].
There is no evidence yet for acidiﬁcation of HIV-containing endosomes.
Thewhole gp41 protein including TMand endodomain is likelymin-
imally trimeric during all steps of viral fusion. The initial gp160 complex
contains three gp41 and three gp120 subunits with the three NHR
helices forming a bundle at the center of the complex [48]. After bindingof the three gp120's to host cell receptors, the gp120's move away from
the gp41's. The NHR bundle may dissociate with subsequent formation
of three NHR/CHR monomer ectodomain hairpins. These monomer
hairpins are hyperthermostable with Tm ≈ 110 °C [14,17]. Evidence
for the ectodomainmonomer as an intermediate in viral fusion includes
fusion inhibitors that could bind to the ectodomain hairpin monomer
but not to theﬁnal trimer of hairpins (six-helix bundle) state. The inhib-
itorswould reduce the oligomer populations of trimer and hexamer and
consequently the intermolecular antiparallel FP β sheet [10,45]. This
interpretation of the peptide inhibition supports the role of this sheet
for hemifusion and viral infection.
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